Fox Run Management L.L.C. Acquires New Stake in Teleflex Incorporated $TFX

Key Points

• Fox Run Management L.L.C. invested $752,000 in Teleflex Incorporated, purchasing 5,439 shares during the first quarter.
• Several institutional investors significantly increased their holdings in Teleflex, with Public Sector Pension Investment Board raising its stake by 2,440.9%.
• Teleflex recently reported quarterly earnings of $3.73 EPS, surpassing expectations and showing a revenue increase of 4.2% year-over-year.

Fox Run Management L.L.C. purchased a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 5,439 shares of the medical technology company's stock, valued at approximately $752,000.

Other institutional investors have also added to or reduced their stakes in the company. Banque Cantonale Vaudoise acquired a new position in Teleflex during the 1st quarter worth approximately $27,000. MassMutual Private Wealth & Trust FSB raised its stake in shares of Teleflex by 103.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock worth $27,000 after purchasing an additional 100 shares during the last quarter. Costello Asset Management INC purchased a new stake in shares of Teleflex in the first quarter worth approximately $28,000. Whipplewood Advisors LLC raised its stake in shares of Teleflex by 7,700.0% in the first quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock worth $32,000 after purchasing an additional 231 shares during the last quarter. Finally, Allworth Financial LP raised its stake in shares of Teleflex by 504.8% in the first quarter. Allworth Financial LP now owns 254 shares of the medical technology company's stock worth $34,000 after purchasing an additional 212 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have recently commented on the company. Morgan Stanley lowered their price objective on Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research note on Monday, May 5th. Truist Financial lowered their price objective on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a research note on Monday, May 5th. Royal Bank Of Canada increased their price objective on Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a research note on Friday, August 1st. Wells Fargo & Company lowered their price objective on Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. Finally, Wall Street Zen raised Teleflex from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 2nd. One research analyst has rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $141.57.

Insider Buying and Selling at Teleflex

In related news, Director Stuart A. Randle purchased 1,000 shares of the business's stock in a transaction dated Tuesday, August 5th. The stock was purchased at an average cost of $115.86 per share, with a total value of $115,860.00. Following the completion of the acquisition, the director directly owned 7,547 shares of the company's stock, valued at approximately $874,395.42. The trade was a 15.27% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Andrew A. Krakauer purchased 1,000 shares of the business's stock in a transaction dated Tuesday, August 5th. The stock was bought at an average cost of $115.25 per share, with a total value of $115,250.00. Following the completion of the acquisition, the director directly owned 7,192 shares of the company's stock, valued at approximately $828,878. This trade represents a 16.15% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 5,500 shares of company stock valued at $633,590 in the last quarter. Insiders own 1.40% of the company's stock.

Teleflex Stock Performance

NYSE TFX traded up $1.24 on Wednesday, hitting $125.54. 359,144 shares of the stock traded hands, compared to its average volume of 792,247. The business's fifty day moving average is $117.85 and its two-hundred day moving average is $131.65. Teleflex Incorporated has a 12 month low of $108.90 and a 12 month high of $249.90. The firm has a market capitalization of $5.55 billion, a price-to-earnings ratio of 29.53, a PEG ratio of 1.67 and a beta of 1.08. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, beating the consensus estimate of $3.36 by $0.37. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The business had revenue of $780.90 million during the quarter, compared to analyst estimates of $771.53 million. During the same period in the prior year, the company earned $3.42 earnings per share. Teleflex's revenue was up 4.2% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, equities analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 15th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Friday, August 15th. Teleflex's dividend payout ratio is 32.00%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.